Contact Us

Events Calendar

2015 Events and Speaking Engagements

Protein and Antibody Engineering Summit European Summit (PEGS Europe)

Location: Lisbon, Portugal

Date: November 2-6, 2015

 

Title: "Rational ADC formulation design as a tool to prevent chemical and physical instabilities"

 

 

GTC Bio

Location: Boston MA

Date: October 22-23, 2015

 

Title: "Chemical and physical stability considerations for antibody-drug conjugates"

 

 

Biopharmaceutical Development & Production (BDP) Week

Location: Huntington Beach, CA

Date: March 30-April 2, 2015

 

Title: "Formulation Development of Antibody Drug Conjugates"

 

 

The Essential Protein Engineering Summit Boston

Location: Boston, MA

Date: May 7, 2015

 

Title: "Physicochemical and Biophysical Characterization of Antibody Drug Conjugates"

 

 

2014 Events and Speaking Engagements

NIH Training Course in Neurotherapuetics Drug Discovery and Development for Academic Scientists

Location: Bethesda, MD

Date: February 19-22, 2014

 

Title: "Formulation and Route of Administration"

 

 

247th ACS National Meeting

Location: Dallas, TX

Date: March 16-20, 2014

 

Title: "Factors Influencing the Aggregation Propensity of Fc-conjugates"

 

 

IBC's Biopharmaceutical Development & Production Week

Location: San Diego, CA

Date: March 23-27, 2014

 

Title: "Key Attributes and Considerations for Developing Antibody Drug Conjugates."

 

 

2013 Events and Speaking Engagements

2013 AAPS Annual Meeting Formulation Design and Development Open Forum on “Strategic Alliances with Universities, Spin-offs, Start-ups, and Research Institutions for Co-Creation of Enabling Technologies throughout the Drug Development Value Chain.”

Organization: American Association of Pharmaceutical Scientists

Location: Henry Gonzalez Convention Center, San Antonio, TX

Date: November 14, 2013
Time: 1:30-5:00

 

Program: Dr. Wolfe will present on, “Phase 0 and Phase I: Drug-Discovery Interface – Co-Creation of New Technology to Enable Rapid Progression to Early Phase Research Formulations and Early Phase Human Clinical Trials.

 

 

Vanderbilt University Postdoctoral Association’s Annual Postdoctoral Research and Shared Resources Symposium

Organization: Vanderbilt University Postdoctoral Association

Location: Nashville, Tennessee

Date: April 30, 2013

 

Presentation Details: Dr. Wolfe delivered the keynote address, titled, “Bridging Basic and Applied Biomedical Research in Translational Drug Development.

 

 

AAPS – Northeast Regional Discussion Group

Organization: American Association of Pharmaceutical Scientists

Location: Rocky Hill, Connecticut

Date: April 19, 2013

 

Panel Discussion: Dr. Wolfe participated in the panel discussion, “Biologics…The Next Challenge.”

 

 

National Meeting of the American Chemical Society

Organization: American Chemical Society

Location: New Orleans, Louisiana

Date: April 7-11, 2013

 

Abstract Presentation: The abstract titled, “The influence of payload on the physiochemical stability of Fc-conjugates,” details how scientists at Wolfe Laboratories, along with their University of Kansas collaborators, have found that conjugation site heterogeneity in ADCs affects the overall surface charge, which can lead to variable and unpredictable pharmaceutical performance.

 

 

2012 Events and Speaking Engagements

Formulation Development Course - Fundamentals of Nanomedicine

Organization: Wolfe Laboratories, Inc.

Location: Wolfe Laboratories' facility

134 Coolidge Avenue

Watertown, MA 02472

Date: November 8, 2012; 8:00am - 6:00pm

 

Program: This course is the latest in a series we started a few years ago, and it is intended to provide a foundation for people who are involved in early drug development.

 

Nanotechnology presents attractive solutions for the development of stable, commercially viable pharmaceutical products. Every nanoscale therapeutic presents a number of unique challenges that must be appropriately understood and addressed during the formulation development process. Fundamentals of Nanomedicine is designed to impart to scientists the tools and knowledge necessary to systematically approach the development of nanomedicines.

 

The course will provide an overview of the nanomedicine industry and detail the development of nanoscale therapeutics including small-molecule nanocrystals, polymer-based drugs, siRNA nanoparticles, and nanoparticles for targeted drug delivery. These case studies will be used to illustrate important aspects of product development to allow scientists to gain firsthand knowledge of solutions to real-world challenges in the development of nanoscale formulations.

 

Attendees will include scientists (B.S.-Ph.D.) from Boston-area biopharmaceutical companies. These scientists are eager to learn practical applications so that they are better equipped to perform their job. One-on-one sessions with speakers are available on a first come, first served basis. Complimentary breakfast and lunch provided, along with two facility tours during morning and afternoon breaks. Attendees will receive booklets of the relevant course information. The event will conclude with a networking cocktail reception. Limit of 50 seats available. Cost of $85 - no refunds.

 

Topics: The course will cover topics such as: The State of the Nanomedicine IndustryNew Challenges and Frontiers in Polymer CharacterizationOral Formulations of Small Molecule Nanocrystals;Nanoparticle Formulations of siRNANanotechnology Approaches to Tumor Targeting; andCharacterization of Disorder by Solid State Analytical Methods: Challenges upon Transition from Macroscopic to Nano Length Scales.

 

Speakers: Roy Haskell, Ph.D., Research Fellow, Discovery Pharmaceutics, Bristol-Myers Squibb; Eugene Zhorov, Ph.D.; Karen Thompson, Ph.D., Distinguished Research Investigator, Pharmaceutical Research, Merck; Muthiah Manoharan, Ph.D., Senior Vice President, Drug Discovery, Alnylam; Caroline McGregor, Ph.D., Director, Basic Pharmaceutical Sciences, Merck; Ales Medek, Ph.D., Scientific Fellow, Vertex Pharmaceuticals

 

To request an invitation: e-mail events@wolfelabs.com.

 

 

2012 AAPS Annual Meeting

Organization: American Association for Pharmaceutical Scientists

Location: McCormick Place

2301 S. Lake Shore Drive

Chicago, Illinois 60616

Date: October 14-18, 2012

Hot Topic Session: The Changing Pharmaceutical Sciences Career — Strategies for Staying Productive and Successful

Session TimeMonday, October 15, 2012, 12:00 pm - 01:15 pm

Presented by: Annette Bak, Ph.D., D irector, Formulation and Basic Pharmaceutical Sciences & Outsourcing Capability Lead, Merck; Janet Wolfe, Ph.D., President, Wolfe Laboratories; Susan Hershenson, Ph.D., President, Pharmaceutical Transformations; and Thomas E. Prisinzano, Ph.D., Associate Professor, Department of Medicinal Chemistry, University of Kansas

Program: The AAPS Annual Meeting and Exposition provides scientists, media, and the public with an opportunity to explore and discuss timely issues related to research and development in the pharmaceutical field. Wolfe Laboratories is participating in the APQ Graduate Student Awards and theDrug Design and Discovery (DDD) Section's Graduate Student Symposium.  This program recognizes excellence in graduate education in the fields of drug design and discovery.

 

 

2012 AAPS-NERDG Annual Meeting

Organization: AAPS Northeast Regional Discussion Group (NERDG)

Location: Marriott Hotel

100 Capital Boulevard

Rocky Hill, CT 06067

Date: April 20, 2012; 8am-4pm

Round Table Session 1: Characterization and Formulation of Antibody-Drug Conjugates. Presented by:Janet Wolfe, PhD, President, Wolfe Laboratories; Palani Palaniappan, PhD, Site Head, Biologics CMC Group, Takeda Millennium; Nathan Fishkin, PhD, Research Scientist, Immunogen; and Edmund Graziani, PhD, Research Fellow, Pfizer

Round Table Session 2: The Technology and Role of Delivery-Enabling Capabilities in Pharmaceutical R&D. Presented by: David Casebier, PhD, Vice President of Pharmaceutical Sciences, Wolfe Laboratories; Jinquan Dong, PhD, Head of Pre-formulation, Biogen;  Robert Garmise, PhD, Research Investigator, Bristol-Myers Squibb; and Sudhakar Garad, Ph.D. Group Head, Novartis Institute for Biomedical Research.

Program: For more than a decade, the NERDG annual meetings have provided a forum for participants to present and discuss research results in an atmosphere that is conducive to social interaction and open exchange of ideas.

 

 

2012 ACS National Spring Meeting and Exposition

Organization: American Chemical Society

Location: San Diego Convention Center

111 West Harbor Drive

San Diego, CA 92101

Date: March 25-29, 2012

Program: More than 14,000 scientists from all disciplines of chemistry are expected to attend the 243rd ACS National Meeting. The theme for this year’s meeting is: The Chemistry of Life. Wolfe Laboratories is participating in the Division for Biotechnology’s session on Biophysical and Biomolecular Processes. The session is scheduled for Monday, March 26th from 8:30am - 11:00am.This program will highlight protein characterization technologies that aid in determining protein structure, stability and dynamics.